Syntel, Inc. today announced that James "Jim" Swayzee, former partner at Accenture, has joined the Company's Board of Directors.
"Jim's deep, international experience in management consulting and strategic planning make him a valuable asset to our board," said Bharat Desai, Syntel's Chairman and CEO. "We look forward to his contributions as Syntel embarks on the next chapter of our its global growth strategy."
With the addition of Mr. Swayzee, Syntel's board will now consist of seven members.
"In its 26-year history, Syntel has built a very dynamic and relevant business model that meets the needs of today's global corporations and I've been impressed with the solid operating performance the organization has consistently delivered," said Mr. Swayzee. "I look forward to leveraging my experience to drive enhanced value to all of Syntel's stakeholders."
Mr. Swayzee has more than 30 years of experience in management consulting, business development, sales & marketing management, and innovation sourcing across Europe and the US. Most recently, he served as a partner in the Pharmaceutical and Medical Products practice at Accenture in New York. Prior to that, he spent 12 years in various management roles at Eli Lilly & Co., the last of which was as Director of Corporate Business Development, where he had responsibility for establishing new business ventures in Europe, Africa and the US. For the eight years preceding Eli Lilly, Mr. Swayzee provided was a management consultant with Booz, Allen & Hamilton in Paris and New York. Mr. Swayzee will stand for election to the Syntel Board of Directors with the other director nominees at the Company's 2007 Annual Shareholder Meeting.
He holds a Bachelor's degree from Wabash College and a Masters of Science degrees in International Business and Economics from the Universities of Munich and Southern California. Mr. Swayzee is also a member of the Board of Trustees of the International School of Paris and President of its U.S. Investment Corporation.